| 产品编号 | CFN93314 | |
| CAS编号 | 123948-87-8 | |
| 分子式 = 分子量 | C23H23N3O5 = 421.45 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | The herbs of Camptotheca acuminata Decne | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 拓扑替康 | CFN93314 | 123948-87-8 | 10mg | QQ客服:3004468520 |
| 拓扑替康 | CFN93314 | 123948-87-8 | 20mg | QQ客服:3004468520 |
| 拓扑替康 | CFN93314 | 123948-87-8 | 50mg | QQ客服:3004468520 |
| 拓扑替康 | CFN93314 | 123948-87-8 | 100mg | QQ客服:3004468520 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | TLyp-1-functionalized topotecan-loaded niosomes could significantly improve anti-glioma treatment. Preparation of topotecan into a temperature-sensitive phase-change hydrogel achieves a long-term sustained antitumor effect on Rb cells, and may be a useful strategy for the treatment of intraocular Rb. | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.3728 mL | 11.8638 mL | 23.7276 mL | 47.4552 mL | 59.319 mL |
| 5 mM | 0.4746 mL | 2.3728 mL | 4.7455 mL | 9.491 mL | 11.8638 mL |
| 10 mM | 0.2373 mL | 1.1864 mL | 2.3728 mL | 4.7455 mL | 5.9319 mL |
| 50 mM | 0.0475 mL | 0.2373 mL | 0.4746 mL | 0.9491 mL | 1.1864 mL |
| 100 mM | 0.0237 mL | 0.1186 mL | 0.2373 mL | 0.4746 mL | 0.5932 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 盐酸育亨宾; Yohimbine Hydrochloride | CFN99511 | 65-19-0 | C21H26N2O3 HCL = 390.91 | 20mg | QQ客服:3004468087 |
| 氟苯尼考; Florfenicol | CFN94552 | 73231-34-2 | C12H14Cl2FNO4S = 358.2 | 20mg | QQ客服:3004468091 |
| 柘树口山酮 A; Cudratricusxanthone A | CFN89371 | 740810-42-8 | C23H24O6 = 396.43 | 5mg | QQ客服:3004468091 |
| Triptohairic acid; Triptohairic acid | CFN91912 | 220209-71-2 | C21H28O3 = 328.45 | 5mg | QQ客服:3004468087 |